Yuri Deigin is CEO of Youthereum Genetics. His company is developing therapies that focus on OSKM, the four Yamanaka factors known for turning cells back into a pluripotent state. Youthereum Genetics is developing an epigenetic rejuvenation gene therapy of aging, building on a 2006 Nobel prize winning work, in which Shinya Yamanaka has shown that an adult cell can be 'reprogrammed' back to embryon...